158 related articles for article (PubMed ID: 17203998)
1. Development and characterization of novel monoclonal antibodies against tartrate-resistant acid phosphatase 5.
Ohashi T; Miura T; Igarashi Y; Kiyokawa I; Sato Y; Sasagawa K; Katagiri K; Mochizuki Y; Tomonaga T; Nomura F; Kojima R; Katayama K
Hybridoma (Larchmt); 2006 Dec; 25(6):358-66. PubMed ID: 17203998
[TBL] [Abstract][Full Text] [Related]
2. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
Janckila AJ; Parthasarathy RN; Parthasarathy LK; Seelan RS; Hsueh YC; Rissanen J; Alatalo SL; Halleen JM; Yam LT
J Leukoc Biol; 2005 Feb; 77(2):209-18. PubMed ID: 15542543
[TBL] [Abstract][Full Text] [Related]
3. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
[TBL] [Abstract][Full Text] [Related]
4. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
Janckila AJ; Simons RM; Yam LT
Clin Chim Acta; 2004 Sep; 347(1-2):157-67. PubMed ID: 15313154
[TBL] [Abstract][Full Text] [Related]
5. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
[TBL] [Abstract][Full Text] [Related]
6. Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
Janckila AJ; Nakasato YR; Neustadt DH; Yam LT
J Bone Miner Res; 2003 Oct; 18(10):1916-9. PubMed ID: 14584907
[TBL] [Abstract][Full Text] [Related]
7. Stable expression of human tartrate-resistant acid phosphatase isoforms by CHO cells.
Janckila AJ; Parthasarathy RN; Parthasarathy LK; Seelan RS; Yam LT
Clin Chim Acta; 2002 Dec; 326(1-2):113-22. PubMed ID: 12417102
[TBL] [Abstract][Full Text] [Related]
8. Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum.
Nakanishi M; Yoh K; Miura T; Ohasi T; Rai SK; Uchida K
Clin Chem; 2000 Apr; 46(4):469-73. PubMed ID: 10759470
[TBL] [Abstract][Full Text] [Related]
9. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
Uchida K; Nakanishi M; Yoh K
Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
[TBL] [Abstract][Full Text] [Related]
10. Tartrate-resistant acid phosphatase as an immunohistochemical marker for inflammatory macrophages.
Janckila AJ; Slone SP; Lear SC; Martin A; Yam LT
Am J Clin Pathol; 2007 Apr; 127(4):556-66. PubMed ID: 17369130
[TBL] [Abstract][Full Text] [Related]
11. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Mose S; Menzel C; Kurth AA; Obert K; Breidert I; Borowsky K; Böttcher HD
Anticancer Res; 2003; 23(3C):2783-8. PubMed ID: 12926113
[TBL] [Abstract][Full Text] [Related]
12. Specificity and clinical performance of two commercial TRACP 5b immunoassays.
Ylipahkala H; Fagerlund KM; Janckila AJ; Houston B; Laurie D; Halleen JM
Clin Lab; 2009; 55(5-6):223-8. PubMed ID: 19728556
[TBL] [Abstract][Full Text] [Related]
13. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
[TBL] [Abstract][Full Text] [Related]
14. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Janckila AJ; Takahashi K; Sun SZ; Yam LT
Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
[TBL] [Abstract][Full Text] [Related]
16. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Halleen JM
Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
[TBL] [Abstract][Full Text] [Related]
17. A change of osteocalcin (OC) and tartrate resistant acid phosphatase 5b (TRACP-5b) with the menstrual cycle.
Lee S; Kumagai T; Hashimoto J; Satoh A; Suzuki T; Yamai K; Ohta S
Horm Metab Res; 2012 Sep; 44(9):699-703. PubMed ID: 22517558
[TBL] [Abstract][Full Text] [Related]
18. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L
Chin Med J (Engl); 2014; 127(16):2894-9. PubMed ID: 25131223
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
Mose S; Menzel C; Kurth AA; Obert K; Ramm U; Eberlein K; Boettcher HD; Pichlmeier U
Anticancer Res; 2005; 25(6C):4639-45. PubMed ID: 16334155
[TBL] [Abstract][Full Text] [Related]
20. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]